Latest SOD1 Stories
A new study from the University of British Columbia and Vancouver Coastal Health Research Institute has discovered how amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, spreads.
WASHINGTON, Feb. 4, 2014 /PRNewswire-USNewswire/ -- The ALS Association is pleased to announce the awarding of five new grants to investigate the causes and treatment of ALS.
Slowdowns in the transport and delivery of nutrients, proteins and signaling molecules within nerve cells may contribute to the development of the neurodegenerative disorder ALS.
An investigational treatment for an inherited form of Lou Gehrig’s disease has passed an early phase clinical trial for safety.